Clinical features and outcomes of pediatric breakthrough invasive pneumococcal disease (IPD) in vaccinated children in Calgary, Alberta, Canada, 2003-2024.

Doucette EJ, Ricketson LJ, Murguía-Favela L, Wright N, Kellner JD

Open source

DOI
10.1016/j.vaccine.2026.128977
Published
2026 Sep 17
Container
Vaccine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2026.128977,
  title = {Clinical features and outcomes of pediatric breakthrough invasive pneumococcal disease (IPD) in vaccinated children in Calgary, Alberta, Canada, 2003-2024.},
  author = {Doucette EJ and Ricketson LJ and Murguía-Favela L and Wright N and Kellner JD},
  year = {2026},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2026.128977},
  url = {https://doi.org/10.1016/j.vaccine.2026.128977}
}

RIS

TY  - JOUR
TI  - Clinical features and outcomes of pediatric breakthrough invasive pneumococcal disease (IPD) in vaccinated children in Calgary, Alberta, Canada, 2003-2024.
AU  - Doucette EJ
AU  - Ricketson LJ
AU  - Murguía-Favela L
AU  - Wright N
AU  - Kellner JD
PY  - 2026
JO  - Vaccine
DO  - 10.1016/j.vaccine.2026.128977
UR  - https://doi.org/10.1016/j.vaccine.2026.128977
ER  - 

APA

EJ, D., LJ, R., L, M., N, W., & JD, K. (2026). Clinical features and outcomes of pediatric breakthrough invasive pneumococcal disease (IPD) in vaccinated children in Calgary, Alberta, Canada, 2003-2024.. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128977

Source records